• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SOFRADIM PRODUCTION UNKNOWN PARIETEX PRODUCT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SOFRADIM PRODUCTION UNKNOWN PARIETEX PRODUCT Back to Search Results
Model Number UNKNOWN PARIETEX
Device Problem Entrapment of Device (1212)
Patient Problems Abscess (1690); Bacterial Infection (1735); Edema (1820); Fatigue (1849); Fever (1858); Inflammation (1932); Staphylococcus Aureus (2058); Chills (2191); Hernia (2240); Therapeutic Response, Decreased (2271); Reaction (2414); Abdominal Distention (2601); Fluid Discharge (2686)
Event Type  Injury  
Event Description
Case report a (b)(6)-year-old white male with hypertension, hyperlipidemia, former smoker who quit over 30 years before presentation, had bilateral open inguinal hernia repairs in his 20s.He developed a recurrent left inguinal hernia in 1999, which was treated with a laparoscopic transabdominal repair.In 2010, he experienced a symptomatic recurrence on the contralateral side.He was seen in clinic at our institution, and he agreed to a recurrent right inguinal hernia repair by a tep approach.The operation was uncomplicated and straightforward.A 6 to 4-inch parietex anatomic mesh (covidien, b)(4)), was used and a thin layer of a fibrin sealant (2 ml tissel; baxter, (b)(4)) was sprayed using a cannula to secure the mesh in the preperitoneal place.The patient was discharged home the same day and returned to his activities 1 week after the operation.The patient did very well for 3 years without any complication.In 2013, he presented after he noticed a "pop" and an enlarging right inguinal bulge.In addition, he also experienced increasing fatigue, fevers and chills, and he lost approximately 30 lbs over the past 2 months.An abdominal computed tomography was obtained, revealing a multiloculated retroperitoneal fluid collection measuring 5.4 to 10.4 cm (figs.1, 2).He was admitted to the hospital, placed on iv piperacillin and tazobactam followed by percutaneous drainage of the retroperitoneal abscess.His antibiotic coverage was changed to ampicillin/sulbactam, as the cultured abscess fluid returned (b)(6).The goal of percutaneous drainage was to adequately drain the abscess cavity and reduce the inflammatory reaction in the groin in preparation for mesh removal and repair of the hernia defect.He underwent a colonoscopy to ascertain potential causes for the mesh infection.No lesions suspicious for malignancy were found on colonoscopic evaluation, although a mild cecal colitis was noted.The patient subsequently underwent elective excision of his right inguinal mesh, and repair of the hernia defect with biological mesh.During the operation, significant inflammation and edema was encountered during the dissection in the right inguinal area.The mesh was found correctly placed under the right rectus, with its inferomedial aspect embedded in the pubic bone.Once the mesh was completely removed without damaging the cord structures, a resulting 4 to 6 cm defect in the floor of the inguinal canal was closed with a biological mesh, allomax surgical graft (davol (b)(4)) and secured with 2-0 prolene to the inguinal ligament, conjoint tendon, and internal oblique muscle.The wound was left open and a v.A.C.(kci, (b)(4)) dressing was applied, with the goal of reducing the risk of seroma and infection.At 2-week follow-up, the patient's incision was healing well.At 8-month follow-up, the patient was doing well without any hernia recurrence or wound complications.
 
Manufacturer Narrative
(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNKNOWN PARIETEX PRODUCT
Type of Device
UNKNOWN PARIETEX PRODUCT
Manufacturer (Section D)
SOFRADIM PRODUCTION
116 avenue du formans
trevoux
FR 
Manufacturer (Section G)
SOFRADIM PRODUCTION
116 avenue du formans
trevoux
FR  
Manufacturer Contact
sharon murphy
60 middletwon ave
north haven, CT 06473
2034925267
MDR Report Key4714542
MDR Text Key5667415
Report Number9615742-2015-00027
Device Sequence Number1
Product Code OTP
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature,Health Professional
Reporter Occupation Physician
Type of Report Initial
Report Date 04/01/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberUNKNOWN PARIETEX
Device Catalogue NumberUNKNOWN PARIETEX
Device Lot NumberNOT AVAILABLE
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 04/01/2015
Initial Date FDA Received04/21/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Other; Required Intervention;
Patient Age78 YR
-
-